Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2006-9-14
pubmed:abstractText
Pyrrolo[1,2-b][1,2,5]benzothiadiazepine 5,5-dioxides (PBTDs) induced apoptosis in human BCR-ABL-expressing leukemia cells. The apoptotic activity was also observed in primary leukemic blasts, obtained from chronic myelogenous leukemia (CML) patients at onset or from patients in blast crisis and who were imatinib-resistant. Compounds 5 and 14 induced apoptosis before BCR-ABL protein expression and tyrosin phosphorylation were affected and activated different caspases in the apoptotic pathway. PBTDs are a new class of valid candidates for the treatment of CML.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Bcr-Abl tyrosine kinase, http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CASP8 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CASP9 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 8, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 9, http://linkedlifedata.com/resource/pubmed/chemical/Caspases, http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Thiazepines, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5840-4
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16970408-Antineoplastic Agents, pubmed-meshheading:16970408-Apoptosis, pubmed-meshheading:16970408-Bone Marrow Cells, pubmed-meshheading:16970408-Caspase 3, pubmed-meshheading:16970408-Caspase 8, pubmed-meshheading:16970408-Caspase 9, pubmed-meshheading:16970408-Caspases, pubmed-meshheading:16970408-Drug Resistance, Neoplasm, pubmed-meshheading:16970408-Enzyme Activation, pubmed-meshheading:16970408-Fusion Proteins, bcr-abl, pubmed-meshheading:16970408-Humans, pubmed-meshheading:16970408-K562 Cells, pubmed-meshheading:16970408-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:16970408-Piperazines, pubmed-meshheading:16970408-Protein-Tyrosine Kinases, pubmed-meshheading:16970408-Pyrimidines, pubmed-meshheading:16970408-Pyrroles, pubmed-meshheading:16970408-Thiazepines, pubmed-meshheading:16970408-Tumor Cells, Cultured
pubmed:year
2006
pubmed:articleTitle
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant.
pubmed:affiliation
Dipartimento di Studi Farmaceutici, Università La Sapienza, Piazzale Aldo Moro 5, I-00185 Roma, Italy. romano.silvestri@uniroma1.it
pubmed:publicationType
Journal Article